Ensysce Biosciences, Inc. (ENSC) vs Pluri Inc. (PLUR)
- Ensysce Biosciences, Inc. ENSC 0.52 −13.33%
- Pluri Inc. PLUR 0.93 −1.06%
Ensysce Biosciences, Inc. and Pluri Inc. are both Biotechnology companies. Ensysce Biosciences, Inc. and Pluri Inc. are of similar size ($11.9M and $11.6M). Pluri Inc. grew revenue faster over the last twelve months: −24.0% against −39.3%. Ensysce Biosciences, Inc. has the higher net margin (−280.5% vs −2,344.6%) and the higher return on invested capital (0.00% vs −526.9%). Across the 17 metrics below, Ensysce Biosciences, Inc. leads on 10 and Pluri Inc. on 7.
Valuation
Profitability
| Metric | ENSC | PLUR | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 44.59% | 65.16% |
| Operating margin | (281.32%) | (2,454.53%) | 0.00% |
| Net margin | (280.49%) | (2,344.59%) | 0.00% |
| Free cash flow margin | (196.76%) | (1,988.48%) | 0.00% |
| Return on equity | (1,295.01%) | 260.35% | (56.36%) |
| Return on assets | (295.92%) | (74.95%) | (48.04%) |
| Return on invested capital | 0.00% | (526.92%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack